Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company X4 Pharmaceuticals Inc.
DescriptionOral small molecule CXC chemokine receptor 4 (CXCR4; NPY3R) antagonist
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCXC chemokine receptor 4 (CXCR4) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today